Vaxon Biotech (France)

A national prevalence study of pressure ulcers in French hospital inpatients

B. Barrois, C. Labalette, Philippe Rousseau et al. · Journal of Wound Care · 2008 · 79 citations

Medicine, Internal Medicine, General Surgery +11

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial

Cesare Gridelli, Tudor–Eliade Ciuleanu, Manuel Dómine et al. · British Journal of Cancer · 2020 · 69 citations · Full text

Medicine, Immunology, Oncology +14

A Phase I Study of the Optimized Cryptic Peptide TERT<sub>572Y</sub> in Patients with Advanced Malignancies

Dimitriοs Mavroudis, Irena Bolonakis, Sébastien Cornet et al. · Oncology · 2006 · 55 citations

Medicine, Oncology, Pharmacology +13

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study

Eleni‐Kyriaki Vetsika, Soultana Christou, Dora Hatzidaki et al. · Annals of Oncology · 2011 · 50 citations · Full text

Medicine, Immunology, Oncology +16

Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001

Eleni‐Kyriaki Vetsika, Georgios Konsolakis, Despoina Aggouraki et al. · Cancer Immunology Immunotherapy · 2011 · 44 citations · Full text

Medicine, Immunology, Oncology +16